Clinical trials: Discerning hype from substance

Annals of Internal Medicine

Volumn 153, Issue 6, 2010, Pages 400-406

  Fleming, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LEVAMISOLE;

DECISION MAKING; EVIDENCE BASED PRACTICE; EXPLORATORY RESEARCH; FALSE POSITIVE RESULT; MEDICAL CARE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SYSTEMATIC ERROR; ARTICLE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH SERVICES RESEARCH; HUMAN; MOTIVATION; STANDARD; STATISTICAL ANALYSIS; STATISTICS;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; EVIDENCE-BASED MEDICINE; GOALS; HEALTH SERVICES RESEARCH; HUMANS;

EID: 77957326656     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-153-6-201009210-00008     Document Type: Review

References (34)

1. Laine C, Goodman SN, Griswold ME, Sox HC. Reproducible research: moving toward research the public can really trust. Ann Intern Med. 2007;146:450-3. [PMID: 17339612]
2. Peng RD, Dominici F, Zeger SL. Reproducible epidemiologic research. Am J Epidemiol. 2006;163:783-9. [PMID: 16510544]
3. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802. [PMID: 10485720]
4. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-68. [PMID: 13678973]
5. Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990;263:1385-9. [PMID: 2406472]
6. Sharp DW. What can and should be done to reduce publication bias? The perspective of an editor. JAMA. 1990;263:1390-1. [PMID: 2304218]
7. Chalmers TC, Frank CS, Reitman D. Minimizing the three stages of publication bias. JAMA. 1990;263:1392-5. [PMID: 2406473]
8. Chalmers I. Underreporting research is scientific misconduct. JAMA. 1990;263:1405-8. [PMID: 2304220]
9. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867-72. [PMID: 1672966]
10. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009:MR000006. [PMID: 19160345]
11. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, et al. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol. 1989;7:1447-56. [PMID: 2778478]
12. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med. 1995;122:321-6. [PMID: 7847642]
13. Morton V, Torgerson DJ. Effect of regression to the mean on decision making in health care. BMJ. 2003;326:1083-4. [PMID: 12750214]
14. Bland JM, Altman DG. Some examples of regression towards the mean. BMJ. 1994;309:780. [PMID: 7950567]
15. Bland JM, Altman DG. Regression towards the mean. BMJ. 1994;308:1499. [PMID: 8019287]
16. Cummings SR, Palermo L, Browner W, Marcus R, Wallace R, Pearson J, et al. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA. 2000;283:1318-21. [PMID: 10714731]
17. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2005;34:215-20. [PMID: 15333621]
18. Suissa S. Lung function decline in COPD trials: bias from regression to the mean [Editorial]. Eur Respir J. 2008;32:829-31. [PMID: 18827150]
19. Atkinson G, Taylor CE, Jones H. Inter-individual variability in the improvement of physiological risk factors for disease: gene polymorphisms or simply regression to the mean? [Letter]. J Physiol. 2010;588:1023-4; author reply 1025. [PMID: 20231148]
20. Rider WD, Palmer JA, Mahoney LJ, Robertson CT. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial. Can J Surg. 1977;20:335-8. [PMID: 871980]
21. Roswit B, Higgins GA, Keehn RJ. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a National Veterans Administration randomized study. Cancer. 1975;35:1597-602. [PMID: 1148993]
22. Medical Research Council Working Party. The evaluation of low dose preoperative X-ray therapy in the management of operable rectal cancer; results of a randomly controlled trial. Br J Surg. 1984;71:21-5. [PMID: 6360300]
23. Fleming TR, Watelet LF. Approaches to monitoring clinical trials. J Natl Cancer Inst. 1989;81:188-93. [PMID: 2642969]
24. Alarcón-Segovia D, Tumlin JA, Furie RA, McKay JD, Cardiel MH, Strand V, et al; LJP 394 Investigator Consortium. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2003;48:442-54. [PMID: 12571854]
25. Cardiel MH, Tumlin JA, Furie RA, Wallace DJ, Joh T, Linnik MD; LJP 394-90-09 Investigator Consortium. Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial. Arthritis Rheum. 2008;58:2470-80. [PMID: 18668592]
26. Study of LJP 394 in Lupus Patients With History of Renal Disease (ASPEN). Accessed at http://clinicaltrials.gov/ct2/show/NCT00089804 on 10 August 2010.
27. U.S. Department of Health and Human Services; U.S. Food and Drug Administration. International Conference on Harmonisation-Efficacy: Guidance for Industry, E9 Statistical Principles for Clinical Trial. 1998. Accessed at www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm073137.pdf on 11 August 2010.
28. Donahue RMJ. Confirmatory trials. In: D'Agostino R, Sullivan L, Massaro J, eds. Wiley Encyclopedia of Clinical Trials. Hoboken, NJ: J Wiley; 2007.
29. Parmar MK, Ungerleider RS, Simon R. Assessing whether to perform a confirmatory randomized clinical trial. J Natl Cancer Inst. 1996;88:1645-51. [PMID: 8931608]
30. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, et al; Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2004;350:125-33. [PMID: 14711911]
31. InterMune. InterMune announces phase III data demonstrating survival benefit of Actimmune in IPF [news release]. Brisbane, CA: InterMune; 28 August 2002.
32. King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, et al; INSPIRE Study Group. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet. 2009;374:222-8. [PMID: 19570573]
33. Emerson SS, Fleming TR. Symmetric group sequential test designs. Biometrics. 1989;45:905-23. [PMID: 2675998]
34. Fleming TR, Sharples K, McCall J, Moore A, Rodgers A, Stewart R. Maintaining confidentiality of interim data to enhance trial integrity and credibility. Clin Trials. 2008;5:157-67. [PMID: 18375654]